CVRx (CVRX) Competitors

CVRx (NASDAQ:CVRX) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, community ranking, profitability, earnings and analyst recommendations.

Is CVRX or DCTH more profitable?

CVRx has a net margin of -116.91% compared to Delcath Systems' net margin of -150.70%. CVRx's return on equity of -93.06% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-116.91%	-93.06%	-51.78%
Delcath Systems	-150.70%	-338.16%	-104.02%

Does the media favor CVRX or DCTH?

In the previous week, CVRx had 5 more articles in the media than Delcath Systems. MarketBeat recorded 11 mentions for CVRx and 6 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.47 beat CVRx's score of 1.13 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Delcath Systems	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, CVRX or DCTH?

CVRx has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.

Does the MarketBeat Community prefer CVRX or DCTH?

CVRx received 3 more outperform votes than Delcath Systems when rated by MarketBeat users. Likewise, 73.47% of users gave CVRx an outperform vote while only 27.50% of users gave Delcath Systems an outperform vote.

Company	Underperform	Outperform
CVRx	Outperform Votes 36 73.47%	Underperform Votes 13 26.53%
Delcath Systems	Outperform Votes 33 27.50%	Underperform Votes 87 72.50%

Do analysts prefer CVRX or DCTH?

CVRx currently has a consensus target price of $14.50, suggesting a potential upside of 131.63%. Delcath Systems has a consensus target price of $22.75, suggesting a potential upside of 31.96%. Given CVRx's higher probable upside, equities research analysts plainly believe CVRx is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Delcath Systems	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders believe in CVRX or DCTH?

75.3% of CVRx shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 13.9% of CVRx shares are owned by insiders. Comparatively, 17.4% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has better earnings and valuation, CVRX or DCTH?

Delcath Systems has higher revenue and earnings than CVRx. Delcath Systems is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$52.87M	3.09	-$59.97M	-$2.18	-2.87
Delcath Systems	$53.85M	11.15	-$47.68M	-$0.50	-34.48

Summary

CVRx beats Delcath Systems on 11 of the 18 factors compared between the two stocks.